2m 2m 2m 2m 2m 2m 2m
TANGO THERAPETCS (TNGX)
NASDAQ
$28.40-$0.10 (-0.35%)
Price as of Jun 23, 2026 4:46 PM EDT- $4.6BMarket Cap
- 435.71%1-Year Change
- BiotechnologyIndustry
TANGO THERAPETCS (TNGX)
$28.40-$0.10 (-0.35%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 62.4M +48.29% | 42.1M +15.17% | 36.5M +46.93% | 24.9M -32.89% | |
Cost of Revenue | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Gross Profit | 62.4M +48.29% | 42.1M +15.17% | 36.5M +46.93% | 24.9M -32.89% | |
Sales and Marketing Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Research and Development Expense | -132.2M -8.17% | -143.9M +24.93% | -115.2M +8.77% | -105.9M +36.41% | |
Depreciation and Amortization Expense | 2.3M -8.72% | 2.5M +3.48% | 2.4M +50.19% | 1.6M +79.26% | |
Total Operating Expenses | 173.7M -7.46% | 187.7M +24.53% | 150.7M +10.87% | 135.9M +42.74% | |
Operating Profit | -111.3M -23.56% | -145.6M +27.52% | -114.2M +2.79% | -111.1M +90.88% | |
Interest Income | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Interest Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Interest Income and Expense and Net | 0 N/A | 0 N/A | 0 N/A | 0 N/A | |
Total Nonoperating Income and Expense | 9.7M -37.43% | 15.5M +23.39% | 12.6M +326.01% | 2.9M +1,093.93% | |
Income before Taxes | -101.6M -21.91% | -130.1M +28.03% | -101.6M -6.02% | -108.1M +86.60% | |
Income Taxes | 4,000 -98.08% | 208,000 +55.22% | 134,000 +148.15% | 54,000 -81.51% | |
Extraordinary Items | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | -101.6M -22.03% | -130.3M +28.07% | -101.7M -5.95% | -108.2M +85.76% | |
Net Income from Continuing Operations Applicable to Common | -101.6M -21.91% | -130.1M +28.03% | -101.6M -6.02% | -108.1M +86.60% | |
Basic EPS and Net Income | -0.87 -26.89% | -1.19 +10.19% | -1.08 -12.20% | -1.23 +30.85% | |
Diluted EPS and Net Income | -0.87 -26.89% | -1.19 +10.19% | -1.08 -12.20% | -1.23 +30.85% | |
Basic Weighted Average Shares | 116.2M +6.35% | 109.2M +15.50% | 94.6M +7.69% | 87.8M +41.40% | |
Diluted Weighted Average Shares | 116.2M +6.35% | 109.2M +15.50% | 94.6M +7.69% | 87.8M +41.40% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 112.3M +61.48% | 69.5M +4.74% | 66.4M +10.70% | 60.0M -57.99% | |
Short-Term Investments | 230.9M +22.55% | 188.4M -30.36% | 270.5M -11.65% | 306.2M -10.61% | |
Cash and Cash Equivalents and Short-Term Investments | 343.1M +33.04% | 257.9M -23.44% | 336.9M -7.99% | 366.1M -24.55% | |
Total Current Assets | 353.8M +32.82% | 266.3M -23.14% | 346.5M -7.66% | 375.3M -23.78% | |
Accumulated Depreciation | 10.5M +26.01% | 8.4M +39.64% | 6.0M +62.70% | 3.7M +45.55% | |
Property and Plant and Equipment and Net | 6.9M -15.23% | 8.1M -18.23% | 9.9M -8.97% | 10.9M +125.25% | |
Total Long-Term Assets | 303,000 +7,475.00% | 4,000 -91.30% | 46,000 +820.00% | 5,000 -73.68% | |
Total Assets | 398.7M +25.97% | 316.5M -21.38% | 402.6M -7.77% | 436.5M -12.73% | |
Income Taxes Payable | N/A N/A | N/A N/A | 35,000 0.00% | 35,000 -32.69% | |
Total Short-Term Debt | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Current Liabilities | 21.7M -43.20% | 38.2M -16.91% | 45.9M -17.30% | 55.5M +36.51% | |
Total Long-Term Debt | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Long-Term Liabilities | 30.8M -60.88% | 78.8M -23.88% | 103.5M -21.25% | 131.4M +2,628,880.00% | |
Total Liabilities | 52.5M -55.11% | 117.0M -21.73% | 149.5M -20.07% | 187.0M +20.32% | |
Retained Earnings | -603.2M +20.26% | -501.6M +35.10% | -371.3M +37.75% | -269.5M +67.05% | |
Total Stockholders Equity | 346.2M +73.51% | 199.5M -21.17% | 253.1M +1.46% | 249.5M -27.64% | |
Total Shares Outstanding | 135.9M +26.19% | 107.7M +5.41% | 102.2M +15.90% | 88.2M +0.66% | |
Cash Flow | |||||
Cash from Operating Activities | -138.9M +5.62% | -131.5M +11.46% | -118.0M +8.16% | -109.1M +83.24% | |
Capital Expenditures | 1.0M +38.99% | 754,000 -50.59% | 1.5M -80.16% | 7.7M +318.73% | |
Cash from Investing Activities | -40.9M -147.45% | 86.1M +107.90% | 41.4M +56.92% | 26.4M +114.39% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | 222.5M +366.81% | 47.7M -42.16% | 82.4M +5,002.54% | 1.6M -99.55% | |
Financials Ratio | |||||
Gross Margin | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Operating Margin | -178.39% -48.45% | -346.09% +10.72% | -312.57% -30.04% | -446.79% +184.41% | |
Return on Assets | -28.41% -21.61% | -36.24% +49.44% | -24.25% +4.99% | -23.10% +32.58% | |
Return on Equity | -37.23% -35.33% | -57.58% +42.20% | -40.49% +11.20% | -36.41% +9.33% | |
Revenue Growth | 48.29% +218.28% | 15.17% -67.67% | 46.93% +242.70% | -32.89% N/A | |
Current Ratio | 16.32 +133.85% | 6.98 -7.50% | 7.54 +11.65% | 6.76 -44.16% | |
Cash Ratio | 5.18 +184.32% | 1.82 +26.05% | 1.45 +33.86% | 1.08 -69.23% | |
Debt-to-Equity Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Debt-to-Assets Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow